U.S. flag An official website of the United States government
  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  4. Gardasil
  1. Vaccines

STN: 125126
Proper Name: Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant
Tradename: Gardasil
Manufacturer: Merck & Co., Inc

Indications:

  • Prevention of vulvar and vaginal cancer
  • Vaccination in females 9 through 26 years of age for prevention of the following diseases caused by Human Papillomavirus (HPV) Types 6, 11, 16, and 18:
    • Cervical cancer
    • Genital warts (condyloma acuminata) and the following precancerous or dysplastic lesions:
      • Cervical adenocarcinoma in situ (AIS)
      • Cervical intraepithelial neoplasia (CIN) grade 2 and grade 3
      • Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3
      • Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3
      • Cervical intraepithelial neoplasia (CIN) grade 1
  • Vaccination in boys and men 9 through 26 years of age for the prevention of genital warts caused by HPV types 6 and 11
  • Vaccination in people ages 9 through 26 years for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18

Product Information

Supporting Documents


Related Information

 
Back to Top